Clinical Trial Update: Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating neuroprotection with magnesium sulfate in women at risk of very preterm birth; the study is completed and investigated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Ischemia
• Intracranial Hemorrhage
• Periventricular Leukomalacia
• Preterm Birth

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Preterm Birth, Periventricular Leukomalacia | Phase 4 | Status: COMPLETED